EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Exploring the Impact of Saccharin on Neovascular Age-Related Macular Degeneration: A Comprehensive Study in Patients and Mice

Steffen E Künzel, Inga-Marie Pompös, Leonie T M Flesch, Dominik P Frentzel, Vitus A Knecht, Silvia Winkler, Sergej Skosyrski, Anne Rübsam, Felix Dreher, Norbert Kociok, Moritz Schütte, Alexandre Dubrac and 6 more

Investigative Opthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.4.5 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, 2024. Written by Steffen E Künzel and 17 co-authors. Institution: Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Ophthalmology, Hin…. Major MEDLINE topics: Choroidal Neovascularization, Macular Degeneration. Cited 5 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

We aimed to determine the impact of artificial sweeteners (AS), especially saccharin, on the progression and treatment efficacy of patients with neovascular age-related macular degeneration (nAMD) under anti-vascular endothelial growth factor (anti-VEGF-A) treatment.

Methods

In a cross-sectional study involving 46 patients with nAMD undergoing intravitreal anti-VEGF therapy, 6 AS metabolites were detected in peripheral blood using liquid chromatography - tandem mass spectrometry (LC-MS/MS). Disease features were statistically tested against these metabolite levels. Additionally, a murine choroidal neovascularization (CNV) model, induced by laser, was used to evaluate the effects of orally administered saccharin, assessing both imaging outcomes and gene expression patterns. Polymerase chain reaction (PCR) methods were used to evaluate functional expression of sweet taste receptors in a retinal pigment epithelium (RPE) cell line.

Results

Saccharin levels in blood were significantly higher in patients with well-controlled CNV activity (P = 0.004) and those without subretinal hyper-reflective material (P = 0.015). In the murine model, saccharin-treated mice exhibited fewer leaking laser scars, lesser occurrence of bleeding, smaller fibrotic areas (P < 0.05), and a 40% decrease in mononuclear phagocyte accumulation (P = 0.06). Gene analysis indicated downregulation of inflammatory and VEGFR-1 response genes in the treated animals. Human RPE cells expressed taste receptor type 1 member 3 (TAS1R3) mRNA and reacted to saccharin stimulation with changes in mRNA expression.

Conclusions

Saccharin appears to play a protective role in patients with nAMD undergoing intravitreal anti-VEGF treatment, aiding in better pathological lesion control and scar reduction. The murine study supports this observation, proposing saccharin's potential in mitigating pathological VEGFR-1-induced immune responses potentially via the RPE sensing saccharin in the blood stream.

Subjects

MeSH terms (MEDLINE)

Choroidal NeovascularizationMacular DegenerationHumansMiceAnimalsVascular Endothelial Growth Factor Receptor-1SaccharinVascular Endothelial Growth Factor ASweetening AgentsCross-Sectional StudiesChromatography, LiquidTandem Mass SpectrometryRNA, MessengerIntravitreal InjectionsAngiogenesis Inhibitors

Substances

Vascular Endothelial Growth Factor Receptor-1SaccharinVascular Endothelial Growth Factor ASweetening AgentsRNA, MessengerAngiogenesis Inhibitors

Authors and institutions

  • Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Ophthalmology, Hindenburgdamm 30, Berlin, Germany.
  • Experimental Ophthalmology, Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität, Berlin Institute of Health, Humboldt-University, Berlin, Germany.
  • Alacris Theranostics, Max-Planck-Straße 3, Berlin, Germany.
  • Département de Pathologie et Biologie Cellulaire, Université de Montréal, Montréal, Quebec, Canada.
  • Max-Planck-Institute for Molecular Genetics, Ihnestrasse 63-73, Berlin, Germany.

Cite

APA

Künzel, S. E., Pompös, I. M., Flesch, L. T. M., Frentzel, D. P., Knecht, V. A., Winkler, S., Skosyrski, S., Rübsam, A., Dreher, F., Kociok, N., Schütte, M., Dubrac, A., Lange, B., Yaspo, M. L., Lehrach, H., Strauß, O., Joussen, A. M., & Zeitz, O. (2024). Exploring the Impact of Saccharin on Neovascular Age-Related Macular Degeneration: A Comprehensive Study in Patients and Mice. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.4.5

Vancouver

Künzel SE, Pompös IM, Flesch LTM, Frentzel DP, Knecht VA, Winkler S, et al. Exploring the Impact of Saccharin on Neovascular Age-Related Macular Degeneration: A Comprehensive Study in Patients and Mice. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.4.5

BibTeX
@article{Knzel2024,
  author = {Künzel, Steffen E and Pompös, Inga-Marie and Flesch, Leonie T M and Frentzel, Dominik P and Knecht, Vitus A and Winkler, Silvia and Skosyrski, Sergej and Rübsam, Anne and Dreher, Felix and Kociok, Norbert and Schütte, Moritz and Dubrac, Alexandre and Lange, Bodo and Yaspo, Marie-Laure and Lehrach, Hans and Strauß, Olaf and Joussen, Antonia M and Zeitz, Oliver},
  title = {Exploring the Impact of Saccharin on Neovascular Age-Related Macular Degeneration: A Comprehensive Study in Patients and Mice},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.4.5}
}
Start for free →